top of page

Videos

Repeat Associated Non-AUG (RAN) Proteins as Therapeutic Targets for C9orf72 ALS/FTD
01:18:29

Repeat Associated Non-AUG (RAN) Proteins as Therapeutic Targets for C9orf72 ALS/FTD

Join us for an insightful session with Laura P.W. Ranum, Ph.D., as she discusses how Repeat Associated Non-AUG (RAN) proteins play a role in C9orf72 ALS/FTD and their potential as therapeutic targets. This talk is part of the EverythingALS Expert Talk Series, bringing you the latest research and advancements in ALS and neurodegenerative diseases. ⏱ Timestamps: ⏱️ 00:00 – Introduction to EverythingALS & Speaker Bio ⏱️ 02:15 – Understanding C9orf72 ALS/FTD: The Basics ⏱️ 05:40 – What Are RAN Proteins? ⏱️ 12:30 – How RAN Translation Contributes to ALS/FTD ⏱️ 18:45 – Targeting RAN Proteins for ALS Therapy ⏱️ 25:10 – Research Updates & Clinical Implications ⏱️ 32:20 – Q&A with Dr. Laura P.W. Ranum 💡 Why This Matters: C9orf72 mutations are the most common genetic cause of ALS and FTD. Understanding RAN proteins could open new doors for therapeutic strategies to combat these devastating diseases. About EverythingALS: EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers. Stay Connected: ► Website: https://www.everythingals.org ► Twitter: https://x.com/everything_als ► LinkedIn: / everythingals ► Facebook: / everythingals ► Subscribe for more Expert Talks: / everythingals #EverythingALS #ALSResearch #Neurodegeneration #C9orf72 #RANProteins #LauraRanum #ALS #FTD
Three Molecular Subtypes of ALS: #ExpertTalk with Dr. Molly Gale Hammell
01:08:48

Three Molecular Subtypes of ALS: #ExpertTalk with Dr. Molly Gale Hammell

In this episode of the EverythingALS Expert Talk Series, Dr. Molly Gale Hammell, Associate Professor at the Institute for Systems Genetics, NYU Langone Medical Center, explores the three molecular subtypes of ALS — stress, inflammation, and TDP-43 pathology. She shares insights into how these distinct pathways contribute to ALS progression and potential avenues for targeted treatments. ⏱ Timestamps: 00:00 - Introduction 02:15 - Understanding ALS at a molecular level 05:40 - The role of cellular stress in ALS 12:20 - Inflammation and its impact on disease progression 18:45 - TDP-43 pathology: Key mechanisms and implications 25:10 - Potential therapeutic strategies 30:00 - Q&A and audience discussion About EverythingALS: EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers. Stay Connected: ► Website: https://www.everythingals.org ► Twitter: https://x.com/everything_als ► LinkedIn: https://www.linkedin.com/everythingals ► Facebook: https://www.facebook.com/EverythingALS ► Subscribe for more Expert Talks: https://www.youtube.com/c/everythingals Don’t forget to: ✅ Like this video if you found it helpful! ✅ Subscribe to our channel for more expert talks and updates: [EverythingALS YouTube Channel]. ✅ Share this video to spread awareness and support ALS research. #ALS #MolecularSubtypes #TDP43 #Neurodegeneration #EverythingALS #ExpertTalk
#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS
56:53

#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS

Welcome to another enlightening #experttalk by the EverythingALS, where we delve into cutting-edge research and innovative approaches to combating #ALS (Amyotrophic Lateral Sclerosis). This discussion dives into the science behind endogenous retroviruses (ERVs), their role in neurodegenerative diseases, and how understanding them could pave the way for innovative treatments for ALS. 🕒 Timestamps 0:00 – Introduction Meet the speakers and an overview of the session. 3:45 – Understanding Endogenous Retroviruses What are ERVs, and why are they significant in neurodegenerative diseases? 10:20 – The Role of ERVs in ALS Pathology How ERVs influence ALS development and progression. 20:15 – Innovative Therapeutic Strategies Exploring cutting-edge research and treatment possibilities targeting ERVs. 30:50 – Q&A with the Experts Addressing audience questions and discussing the future of ALS therapies. 40:25 – Closing Remarks Final insights and takeaways from the session. 👩‍🔬 About EverythingALS: EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers. 📩 Stay Connected: Subscribe to our channel and turn on notifications to stay updated on the latest expert talks and research breakthroughs in ALS. 💡 Don’t forget to: ✅ Like this video if you found it helpful! ✅ Subscribe to our channel for more expert talks and updates: [EverythingALS YouTube Channel]. ✅ Share this video to spread awareness and support ALS research. 📌 For more resources and to participate in EverythingALS initiatives, visit: everythingals.org #ALS #EndogenousRetrovirus #ALSResearch #TherapeuticApproach #EverythingALS #Neurodegeneration
bottom of page